New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - metformin hydrochloride 500mg;  ;   - coated tablet - 500 mg - active: metformin hydrochloride 500mg     excipient: magnesium stearate opadry clear oy-29020 povidone water - -treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. -metformin may be used as initial treatment or in sulfonylurea failures either alone or in combination with a sulfonylurea and other oral agents. - adjuvant therapy in insulin dependent diabetes especially if overweight.

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - metformin hydrochloride 850mg;  ;   - coated tablet - 850 mg - active: metformin hydrochloride 850mg     excipient: magnesium stearate opadry clear oy-29020 povidone water - -treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. -metformin may be used as initial treatment or in sulfonylurea failures either alone or in combination with a sulfonylurea and other oral agents. - adjuvant therapy in insulin dependent diabetes especially if overweight.

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - ranitidine hydrochloride 16.75 mg/ml - syrup - 150 mg/10ml - active: ranitidine hydrochloride 16.75 mg/ml excipient: dibasic sodium phosphate ethanol mint flavour phl-069966 monobasic sodium phosphate dihydrate purified water saccharin sodium sorbitol - arrow-ranitidine syrup is indicated for the treatment of duodenal ulcer, and benign gastric ulcer, including that associated with non-steroidal anti- inflammatory agents.

New Zealand - English - Medsafe (Medicines Safety Authority)

actavis new zealand limited - stavudine 40mg - capsule - 40 mg - active: stavudine 40mg excipient: gelatin lactose liquid paraffin magnesium stearate purified water sodium laurilsulfate   sodium starch glycolate tekprint black sw-9008 titanium dioxide - arrow - stavudine is indicated for the treatment of hiv-infected patients (over the age of 5 months) for whom zidovudine therapy is not, or is no longer, appropriate.

Canada - English - Health Canada

arrow international inc. - lidocaine hydrochloride; povidone-iodine - liquid - 1%; 10% - lidocaine hydrochloride 1%; povidone-iodine 10% - local anesthetics

Canada - English - Health Canada

arrow international inc. - lidocaine hydrochloride; povidone-iodine - liquid - 1%; 10% - lidocaine hydrochloride 1%; povidone-iodine 10% - local anesthetics

Canada - English - Health Canada

arrow international inc. - lidocaine hydrochloride; povidone-iodine; povidone-iodine - liquid - 1%; 10%; 10% - lidocaine hydrochloride 1%; povidone-iodine 10%; povidone-iodine 10% - local anesthetics

Canada - English - Health Canada

arrow international inc. - lidocaine hydrochloride; povidone-iodine - kit - 1%; 10% - lidocaine hydrochloride 1%; povidone-iodine 10% - local anesthetics

Canada - English - Health Canada

arrow international inc. - lidocaine hydrochloride; povidone-iodine; povidone-iodine - liquid - 1%; 10%; 10% - lidocaine hydrochloride 1%; povidone-iodine 10%; povidone-iodine 10% - local anesthetics

Singapore - English - HSA (Health Sciences Authority)

teleflex medical asia pte. ltd. - general hospital - arrow agb+ pressure injectable multi-lumen cvc kit permits venous access to central circulation by way of subclavian, jugular, and femoral veins. the arrowg+ard technology is intended to provide protection against catheter-related bloodstream infections (crbsis). it is not intended to be used as a treatment for existing infections nor is it indicated for long-term use (> 30 days).